NASDAQ:VLON - Nasdaq - US92023M1018 - Common Stock - Currency: USD
Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer T (“NKT”) modulating therapies for the treatment of...
It's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday!
Vallon’s board approves 1-for-30 reverse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) --...
Vallon Pharmaceuticals (VLON) stock is rising higher on Monday despite a lack of news from the clinical-stage biopharmaceutical company.
Mentions: EBET
It's time for another dive into the biggest pre-market stock movers as we see what's moving the market on Thursday morning!
Board of Directors unanimously recommend Vallon stockholders to vote “FOR” all proposals outlined in the Company’s definitive Proxy Statement (the “Proxy”)...
PHILADELPHIA, PA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), today reported its...
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for trader need to kno about Wednesday!
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday!
Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.
Sorrento Therapeutics (SRNE) stock is falling on Monday after the company filed for bankruptcy alongside Scintilla Pharmaceuticals.
G1 Therapeutics (GTHX) stock is falling on Monday after the company announced plans to discontinue a Phase 3 clinical trial.
It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!